Web Analysis for Irontree - irontree.co.za
With IronTree’s cloud backup and business continuity services you can be confident that your data and systems are always safe.
It is a domain having co.za extension. It has a global traffic rank of #3446214 in the world. This website is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently by users, irontree.co.za is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
No Risk Issues
Traffic Report
| Daily Unique Visitors: | 244 |
| Daily Pageviews: | 488 |
Estimated Valuation
| Income Per Day: | $ 2.00 |
| Estimated Worth: | $ 480.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | No Risk Issues |
| WOT Trustworthiness: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Alexa Rank: | 3,446,214 |
| Domain Authority: | Not Applicable |
Web Server Information
Hosted IP Address:
13.244.47.142
Hosted Country:
ZA
Location Latitude:
-33.9258Location Longitude:
18.4232Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 4 |
| H3 Headings: | 19 | H4 Headings: | 23 |
| H5 Headings: | 26 | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 11 | Total Images: | 20 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-8732758-1 |
HTTP Header Analysis
Date: Tue, 08 Dec 2020 04:21:46 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Link: <https://irontree.co.za/wp-json/>; rel="https://api.w.org/", <https://irontree.co.za/wp-json/wp/v2/pages/242>; rel="alternate"; type="application/json", <https://irontree.co.za/>; rel=shortlink
Vary: Accept-Encoding
Content-Encoding: gzip
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns-955.awsdns-55.net |
|
205.251.195.187 |
United States of America
|
| ns-1910.awsdns-46.co.uk |
|
205.251.199.118 |
United States of America
|
| ns-5.awsdns-00.com |
|
205.251.192.5 |
United States of America
|
| ns-1503.awsdns-59.org |
|
205.251.197.223 |
United States of America
|
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| irontree.co.za | A | 7196 |
IP: 13.244.47.142 |
| irontree.co.za | NS | 172800 |
Target: ns-1503.awsdns-59.org |
| irontree.co.za | NS | 172800 |
Target: ns-1910.awsdns-46.co.uk |
| irontree.co.za | NS | 172800 |
Target: ns-5.awsdns-00.com |
| irontree.co.za | NS | 172800 |
Target: ns-955.awsdns-55.net |
| irontree.co.za | SOA | 900 |
MNAME: ns-1503.awsdns-59.org RNAME: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum TTL: 86400 |
| irontree.co.za | MX | 7200 |
Priority: 10 Target: mx02.mep.pandasecurity.com |
| irontree.co.za | MX | 7200 |
Priority: 15 Target: mx01.mep.pandasecurity.com |
| irontree.co.za | TXT | 7200 |
TXT: MS=ms96886410 |
| irontree.co.za | TXT | 7200 |
TXT: v=spf1 a mx ip4:105.242.193.157/32 include:spf.clikitmedia.com include:fw.irontree.co.za include:5066236.spf01.hubspotemail.net include:spf.protection.outlook.com -all |
Similarly Ranked Websites
UK Payments | Supporting progress and enabling change
Founded in 1985, UK Payments has over 30 years' experience of successfully supporting a key element of the financial services sector – the payments industry.
3,446,222
$
480.00
Burhanudin Yahya
Burhanudin Yahya di blog ini akan banyak berbagi opini, kegelisahan, cerita bahkan sampai aktifitas keseharian nya. Baik seputar pengembangan diri ataupun sampai isu sosial-politik. Mampir ya!
3,446,230
$
480.00
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer an
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
3,446,235
$
480.00
